Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Ocuphire Pharma Inc. buy krebskrebs

Start price
€2.58
07.02.22 / 50%
Target price
€3.20
07.02.23
Performance (%)
26.55%
End price
€3.27
08.02.23
Summary
This prediction ended on 08.02.23 with a price of €3.27. The BUY prediction by krebskrebs finished with a performance of 26.55%. krebskrebs has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Ocuphire Pharma Inc. -6.730% -6.730% -65.801%
iShares Core DAX® 1.851% 5.158% 17.711%
iShares Nasdaq 100 1.573% 2.589% 39.053%
iShares Nikkei 225® -0.412% -2.857% 13.501%
iShares S&P 500 1.128% 2.485% 29.871%

Comments by krebskrebs for this prediction

In the thread Ocuphire Pharma Inc. diskutieren
Prediction Buy
Perf. (%) 26.55%
Target price 3.200
Change
Ends at

Buy mit Kursziel 3,2

In the thread Trading Ocuphire Pharma Inc.
Prediction Buy
Perf. (%) 26.55%
Target price 3.200
Change
Ends at 07.02.23

Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

Stopped prediction by krebskrebs for Ocuphire Pharma Inc.

buy
Ocuphire Pharma Inc.

Start price
Target price
Perf. (%)
€7.00
05.10.20
€10.32
04.11.21
-46.29%
05.11.21